Drug:  | 
         PLX9486 + PLX3397  | 
       |||
|---|---|---|---|---|
Trial:  | 
         PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors  | 
       |||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status:  | 
         Completed  | 
       |||
Karmanos Cancer Institute4100 John R       | 
      
Principal Investigator:  | 
        Anthony F. Shields, MD, PhD | 
|---|---|
Contact:  | 
        |
Activation Status of this Site:  | 
        Closed | 
Notes about this Site:  | 
        |
 Karmanos Cancer Institute Website:  | 
        https://app-oncoreprod1.karmanos.org/sip/SIPControlServlet | 
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.